{
  "id": 175519,
  "name": "HUMANA",
  "slug": "humana",
  "state": "KY",
  "description": null,
  "totalSpending": 2320000,
  "filings": 29,
  "yearlySpending": [
    {
      "year": 2018,
      "income": 320000
    },
    {
      "year": 2019,
      "income": 240000
    },
    {
      "year": 2020,
      "income": 320000
    },
    {
      "year": 2021,
      "income": 240000
    },
    {
      "year": 2022,
      "income": 320000
    },
    {
      "year": 2023,
      "income": 320000
    },
    {
      "year": 2024,
      "income": 240000
    },
    {
      "year": 2025,
      "income": 320000
    }
  ],
  "firms": [
    "MEHLMAN CONSULTING, INC."
  ],
  "lobbyists": [
    "BRUCE MEHLMAN",
    "DAVID CASTAGNETTI",
    "DEAN ROSEN",
    "DAVID THOMAS",
    "ELISE FINLEY PICKERING",
    "CHARLES WOOTERS",
    "SOHINI GUPTA",
    "SAGE EASTMAN",
    "LAUREN ARONSON",
    "MICHAEL ROBINSON",
    "MICHAEL COLLINS",
    "CONSTANTINE HINGSON",
    "STEVE HARO",
    "HELEN TOLAR",
    "NICHOLE DISTEFANO",
    "MCKENZIE BRICE",
    "PAUL THORNELL",
    "STEPHEN COTE",
    "ALEXANDER PERKINS",
    "VICTORIA FLOOD",
    "ROSEMARY GUTIERREZ",
    "ZACHARY MALLOVE",
    "CAITLIN VAN SANT",
    "LISA GOLDMAN",
    "ALYENE MLINAR",
    "ERICA CHABOT",
    "ANNIE WOLF",
    "NAVEEN PARMAR",
    "JON ADAME",
    "JOSEPH BROWN",
    "EARL FLOOD"
  ],
  "issues": [
    "TAX",
    "MMM",
    "DEF",
    "HCR",
    "DIS",
    null,
    "PHA"
  ],
  "sampleDescriptions": [
    "Implementation of PL 115-97 (H.R. 1/tax reform).\nHealth Insurance Tax.",
    "S. 637 - Creating Transparency to have Drug Rebates Unlocked (C-THRU).\nS. 870 - Creating High Quality Results and Outcomes Necessary to Improve Chronic Care Act (CHRONIC Act)\nMedicare Advantage Policy and Reimbursement.\nMedicare Part D issues.\nMedicaid and Dual Eligible issues.\nPharmacy Reimbursement issues.\nMedicare Access and CHIP Reauthorization Act Implementation.\nSenate Finance Chronic Care Working Group issues.\nOpioid issues.\nMedicare extenders.\nSpecial Needs Plans Reauthorization\nH.R. 1625 - Consolidated Appropriations Act of 2018.\nH.R. 1892 - Bipartisan Budget Act of 2018.",
    "Tricare Contracts and Implementation issues.\nH.R. 2810 and S. 1510 - FY 2018 National Defense Authorization Act implementation.",
    "H.R. 246 - Jobs and Premium Protection Act.\nACA Implementation, Medicare Advantage, Prescription Drugs.\nS. 1859 -  Healthcare Tax Relief Act.\nS. 1978 - Small Business and Family Health Tax Relief Act of 2017.\nH.R. 4620 - Protecting Families and Small Businesses Act of 2017.\nH.R. 1892 - Bipartisan Budget Act of 2018.",
    "Implementation of PL 115-97 (H.R. 1/tax reform).\nHealth Insurance Tax.\nHSA Tax Treatment.",
    "S. 637 - Creating Transparency to have Drug Rebates Unlocked (C-THRU).\nMedicare Advantage Policy and Reimbursement.\nMedicare Part D issues.\nMedicaid and Dual Eligible issues.\nPharmacy Reimbursement issues.\nMedicare Access and CHIP Reauthorization Act Implementation.\nH.R. 6 - Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act or the SUPPORT for Patients and Communities Act.\nRequest for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.",
    "H.R. 246 - Jobs and Premium Protection Act.\nACA Implementation, Medicare Advantage, Prescription Drugs.\nS. 1859 -  Healthcare Tax Relief Act.\nS. 1978 - Small Business and Family Health Tax Relief Act of 2017.\nH.R. 4620 - Protecting Families and Small Businesses Act of 2017.\nRequest for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.",
    "Tricare Contracts and Implementation issues.\nH.R. 2810 and S. 1510 - FY 2018 National Defense Authorization Act implementation.\nH.R. 5515/S. 2987 - FY 2019 National Defense Authorization Act.",
    "S. 637 - Creating Transparency to have Drug Rebates Unlocked (C-THRU).\nMedicare Advantage Policy and Reimbursement.\nMedicare Part D issues.\nMedicaid and Dual Eligible issues.\nPharmacy Reimbursement issues.\nMedicare Access and CHIP Reauthorization Act Implementation.\nH.R. 6 - SUPPORT for Patients and Communities Act.\nS. 3120 - HEAL Act of 2018.\nRequest for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.",
    "H.R. 246 - Jobs and Premium Protection Act.\nACA Implementation, Medicare Advantage, Prescription Drugs.\nS. 1859 -  Healthcare Tax Relief Act.\nS. 1978 - Small Business and Family Health Tax Relief Act of 2017.\nH.R. 4620 - Protecting Families and Small Businesses Act of 2017.\nRequest for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.\nH.R. 6 - SUPPORT for Patients and Communities Act.\nS. 3120 - HEAL Act of 2018.\nS. 2554 - Patient Right to Know Drug Prices Act.\nH.R. 878; H.R. 2368/S. 204 - Right-to-Try Legislation.",
    "Implementation of PL 115-97 (H.R. 1/tax reform).\nH.R. 246 - Jobs and Premium Protection Act.\nS. 1859 - Healthcare Tax Relief Act.\nHr.R 5963 - Health Insurance Premium Reduction Act.\nS. 3063 - Health Insurance Tax Relief Act of 2018.\nH.R. 6311 - Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018.\nHSA Tax Treatment.",
    "Implementation of PL 115-97 (H.R. 1/tax reform).\nH.R. 246 - Jobs and Premium Protection Act.\nS. 1859 - Healthcare Tax Relief Act.\nH.R. 5963 - Health Insurance Premium Reduction Act.\nS. 3063 - Health Insurance Tax Relief Act of 2018.\nH.R. 6311 - Increasing Access to Lower Premium Plans and Expanding Health Savings Accounts Act of 2018.",
    "Medicare Advantage Policy and Reimbursement.\n2020 Medicare Advantage Advance Rate Notice and Draft Call Letter.\nMedicare Part D issues.\nHHS/OIG RIN0936-AA08 - Removal of Safe Harbor Protection for Rebates Involving Prescription Pharmaceuticals.\nCMS-4180-P - Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses Proposed Rule.\nMedicaid and Dual Eligible issues.\nPharmacy Reimbursement issues.",
    "Tricare issues.\nNDAA Implementation issues.\n2020 NDAA",
    "H.R. 1398/S. 172 - Health Insurance Tax Relief Act.\nTax Reform implementation issues.",
    "Balanced Billing issues.\nPrescription drug pricing\nH.R. 1398/S. 172 - Health Insurance Tax Relief Act.\nCMS-9115-P/HHS ONC RIN-0955-AA01 - 21st Century Cures Interoperability and Information Blocking Proposed Rules.",
    "Tricare issues.\nNDAA Implementation issues.\nH.R. 2500/S. 1790 National Defense Authorization Act of 2020.",
    "Balanced Billing issues.\nPrescription drug pricing\nH.R. 1398/S. 172 - Health Insurance Tax Relief Act\nS. 3063 - Health Insurance Tax Relief Act of 2018\nH.R. 2447 - Jobs and Premium Protection Act\nCMS-9115-P/HHS ONC RIN-0955-AA01 - 21st Century Cures Interoperability and Information Blocking Proposed Rules\nSenate HELP - Lower Health Care Costs Act\nS. 340/H.R. 965 CREATES Act\nH.R. 2296 - Fair Accountability and Innovative Research Act\nH.R. 2113 - Prescription Drug Sunshine, Transparency, Accountability, and Reporting Act\nH.R. 987 - Strengthening Health Care and Lowering Prescription Drug Costs Act\nS. 1280/H.R. 2477 - BENES Act\nH.R. 3 - Lower Drug Costs Now Act of 2019\nS. 2543 - Prescription Drug Pricing Reduction Act of 2019",
    "Medicare Advantage Policy and Reimbursement.\n2021 Medicare Advantage Advance Rate Notice and Draft Call Letter.\nMedicare Part D issues.\nCMS-4180-P - Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Medicaid and Dual Eligible Issues.\nPharmacy Reimbursement issues.",
    "H.R. 1398/S. 172 - Health Insurance Tax Relief Act.\nS. 3063 - Health Insurance Tax Relief Act of 2018.\nH.R. 2447 - Jobs and Premium Protection Act.\nTax Reform implementation issues."
  ],
  "years": [
    2018,
    2019,
    2020,
    2021,
    2022,
    2023,
    2024,
    2025
  ],
  "growthRate": 0,
  "trajectory": "stable",
  "yearsActive": 8,
  "avgAnnualSpending": 290000,
  "peakYear": 2018,
  "lobbyistCount": 31,
  "firmCount": 1,
  "issueCount": 6
}